Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Regeneron Pharmaceuticals -- Ignore unavailable to you. Want to Upgrade?

To: rkrw who wrote (988)	9/27/2005 12:58:18 AM
From: Miljenko Zuanic	Read Replies (2) \| Respond to of 3557

<<vegf trap moving forward>> For now it is PLAN expansion, program is still at ground zero. Maybe Aventis have some preliminary data from combination (in EU). Again, why they are wasting time and money on single agent trials? Combination safety issue? Contract mfg can be very profitable, if one knows how to run business. 730 emp, what a waste of workforce. Or, one asshole covering another! Wish I have a chance to confront them in public place (investor conf, as example). Miljenko PS: For what they wasted millions (and time) on IL-1 trap kg quantity??? THREE pts in pilot trial!!!!